시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 손바닥 다한증 치료 시장 보고서(2025년)
Palmar Hyperhidrosis Treatment Global Market Report 2025
상품코드 : 1769701
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,493,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,386,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,279,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

손바닥 다한증 치료 시장 규모는 향후 몇 년간 강력한 성장이 예상됩니다. 이 예측 기간에 있어서의 치료 과제에는 진단 사례 수 증가, 손바닥의 땀에 관련되는 감정적 및 사회적 과제 증가, 침습성이 낮은 치료법 또는 비외과적 치료법에 대한 관심 증가, 가처분 소득 증가, 정부에 의한 헬스케어 지출 전체 증가 등이 포함됩니다. 예상되는 현저한 시장 동향에는 보툴리눔툭신(보톡스) 제품의 혁신, 이온토포레시스 기술의 강화, 신속한 진단과 치료 선택을 위한 피부과에서 AI 툴의 사용, 새로운 국소 치료 제제의 출현, 로봇 지원 수술 발전 등이 포함됩니다.

손바닥 다한증의 유병률 상승은 향후 수 년간 손바닥 다한증 치료 시장의 성장을 가속할 것으로 예측됩니다. 손바닥 다한증은 손바닥에 과도하고 통제할 수 없는 땀이 나는 상태로, 일반적으로 기저 질환 없이 과도한 신경 활동으로 인해 발생합니다. 손바닥 다한증 환자 증가는 교감 신경계를 과도하게 자극하고 과도한 발한을 일으키는 스트레스와 불안 수준 증가가 주된 원인입니다. 예를 들어, 2023년 1월, 미국에 본사를 둔 의학 연구 부서인 국립 의학 도서관은 다한증(HH)이 영국에서 1.6%, 미국에서 1.0%-4.8%로 추정되는 충분히 조사되지 않은 만성 질환이라고 보고했습니다.

건강 관리 지출 증가는 손바닥 다한증 치료 시장의 성장을 지원할 것으로 예측됩니다. 헬스케어 지출에는 의료 서비스, 치료, 시설, 연구, 건강 상태의 유지 및 개선을 목적으로 하는 공중 보건 활동에 대한 지출 총액이 포함됩니다. 이러한 지출 증가는 더 많은 의료, 치료 및 장기 건강 관리 서비스를 필요로 하는 노인 인구 증가에 의해 야기됩니다. 건강 관리 지출 증가는 botulinum toxin 주사와 같은 전문 치료를 포함하여 고급 치료 및 진단 서비스에 대한 액세스를 강화하고 손바닥 다한증의 치료 결과를 향상시킵니다. 예를 들어 2024년 12월 미국에 본사를 둔 연방기관인 Medicare and Medicaid 서비스 센터(CMS)는 2023년 국민의료비(NHE)가 7.5% 증가한 4조 9,000억 달러에 이르고, 국내총생산(GDP)의 17.6%를 차지한다고 보고했습니다. 게다가 NHE는 2023년부터 2032년까지 연평균 5.6% 성장했으며, GDP에서 차지하는 의료비의 비율은 2022년 17.3%에서 2032년 19.7%로 증가할 것으로 예측됩니다. 그 결과, 헬스케어 지출 증가가 손바닥 다한증 치료 시장의 성장을 견인하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Palmar hyperhidrosis treatment encompasses various medical solutions aimed at managing excessive sweating of the palms, a condition caused by overactive sweat glands. This condition can severely affect daily functioning, social relationships, and mental health. The primary goal of these treatments is to reduce sweat output, promote hand dryness, and ultimately enhance the patient's overall quality of life.

The key types of treatments for palmar hyperhidrosis include topical therapies, oral medications, botulinum toxin injections, iontophoresis, surgical procedures, and other methods. Topical therapies involve directly applying substances like aluminum chloride-based antiperspirants to the skin. This condition affects individuals across all age groups-children, teens, adults, and seniors-and can range in severity from mild to severe. Major end users of these treatment options include hospitals, dermatology and specialty clinics, as well as homecare settings.

The palmar hyperhidrosis treatment market size has grown strongly in recent years. It will grow from $0.90 billion in 2024 to $0.97 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth during the historical period has been supported by increased adoption of tele-dermatology services, heightened awareness from public health campaigns, wider availability and affordability of iontophoresis devices for home use, greater emphasis on improving patient quality of life in treatment protocols, and the expansion of dermatology and specialty care services.

The palmar hyperhidrosis treatment market size is expected to see strong growth in the next few years. It will grow to $1.29 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. Contributing factors in the projected period include a growing number of diagnosed cases, rising emotional and social challenges linked with sweaty palms, increased interest in less invasive or non-surgical treatment alternatives, a rise in disposable income, and higher overall healthcare spending by governments. Prominent market trends expected include innovations in botulinum toxin products, enhancements in iontophoresis technology, the use of AI tools in dermatology for faster diagnosis and treatment selection, the emergence of new topical treatment formulations, and advancements in robotic-assisted surgical techniques.

The rising prevalence of palmar hyperhidrosis is expected to drive the growth of the palmar hyperhidrosis treatment market in the coming years. Palmar hyperhidrosis is a condition marked by excessive, uncontrollable sweating of the palms, typically caused by overactive nerves without any underlying medical condition. The increase in palmar hyperhidrosis cases is largely attributed to growing stress and anxiety levels, which overstimulate the sympathetic nervous system and result in excessive sweating. Treatments for palmar hyperhidrosis help manage this condition by reducing hand sweating, thereby improving comfort and confidence, and enhancing personal and professional interactions. For example, in January 2023, the National Library of Medicine, a U.S.-based medical research department, reported that hyperhidrosis (HH) is an under-recognized and under-researched chronic condition, with its prevalence estimated at 1.6% in the UK and between 1.0% and 4.8% in the USA. As a result, the rising prevalence of palmar hyperhidrosis is contributing to the growth of the treatment market.

The increasing healthcare expenditure is anticipated to support the growth of the palmar hyperhidrosis treatment market. Healthcare expenditure encompasses the total spending on medical services, treatments, facilities, research, and public health initiatives aimed at maintaining or improving health outcomes. This increase in expenditure is driven by a growing aging population that requires more medical care, treatments, and long-term healthcare services. Higher healthcare spending enhances access to advanced therapies and diagnostic services, including specialized treatments like botulinum toxin injections, thereby improving treatment outcomes for palmar hyperhidrosis. For instance, in December 2024, the Centers for Medicare and Medicaid Services (CMS), a U.S.-based federal agency, reported that national health expenditures (NHE) grew by 7.5% to $4.9 trillion in 2023, accounting for 17.6% of the gross domestic product (GDP). Furthermore, NHE is projected to grow at an average annual rate of 5.6% between 2023 and 2032, increasing the health spending share of GDP from 17.3% in 2022 to 19.7% in 2032. Consequently, rising healthcare expenditure is driving the growth of the palmar hyperhidrosis treatment market.

Major companies in the palmar hyperhidrosis treatment market are focusing on developing innovative solutions such as botulinum toxin type A injections to enhance treatment effectiveness, minimize side effects, and improve patient comfort. Botulinum toxin type A is a neurotoxic protein-based treatment that temporarily blocks nerve signals responsible for sweat production, thereby effectively reducing excessive sweating. For instance, in December 2022, Gufic Biosciences Ltd., an India-based pharmaceutical company, introduced Zarbot, a botulinum toxin type A injection. This product offers a cost-effective alternative for treating palmar hyperhidrosis by chemically denervating sweat glands, providing similar efficacy to global brands. Zarbot delivers precise intradermal doses, typically ranging from 100 to 150 units per palm, which block the release of acetylcholine and significantly reduce sweating for approximately 6 to 9 months. As a domestically manufactured option, Zarbot presents a more affordable alternative to imported botulinum toxin treatments and meets international pharmacopoeial standards, making it suitable for widespread clinical use.

Major players in the palmar hyperhidrosis treatment market are AbbVie Inc., GlaxoSmithKline plc, Eli Lilly and Company, Dr. August Wolff GmbH & Co. KG, Merz Pharma GmbH & Co. KGaA, Kaken Pharmaceutical Co. Ltd., Medytox Inc., Revance Therapeutics Inc., Sientra, Alma Lasers Ltd., Journey Medical Corporation, Fotona d.o.o., Person & Covey Inc., Candela Corporation, Brickell Biotech Inc., Avanor Healthcare Ltd, C Cube Advanced Technologies, Dermadry Laboratories Inc., TheraVida Inc., and ThermiGen LLC.

North America was the largest region in the palmar hyperhidrosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in palmar hyperhidrosis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the palmar hyperhidrosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The palmar hyperhidrosis treatment market consists of revenues earned by entities by providing services such as diagnosis and assessment services, customized treatment planning, and psychological counseling and support. The market value includes the value of related goods sold by the service provider or included within the service offering. The palmar hyperhidrosis treatment market also includes sales of clinical-strength antiperspirant wipes, microwave thermolysis devices, and topical anticholinergic creams or gels. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Palmar Hyperhidrosis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on palmar hyperhidrosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for palmar hyperhidrosis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The palmar hyperhidrosis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Palmar Hyperhidrosis Treatment Market Characteristics

3. Palmar Hyperhidrosis Treatment Market Trends And Strategies

4. Palmar Hyperhidrosis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Palmar Hyperhidrosis Treatment Growth Analysis And Strategic Analysis Framework

6. Palmar Hyperhidrosis Treatment Market Segmentation

7. Palmar Hyperhidrosis Treatment Market Regional And Country Analysis

8. Asia-Pacific Palmar Hyperhidrosis Treatment Market

9. China Palmar Hyperhidrosis Treatment Market

10. India Palmar Hyperhidrosis Treatment Market

11. Japan Palmar Hyperhidrosis Treatment Market

12. Australia Palmar Hyperhidrosis Treatment Market

13. Indonesia Palmar Hyperhidrosis Treatment Market

14. South Korea Palmar Hyperhidrosis Treatment Market

15. Western Europe Palmar Hyperhidrosis Treatment Market

16. UK Palmar Hyperhidrosis Treatment Market

17. Germany Palmar Hyperhidrosis Treatment Market

18. France Palmar Hyperhidrosis Treatment Market

19. Italy Palmar Hyperhidrosis Treatment Market

20. Spain Palmar Hyperhidrosis Treatment Market

21. Eastern Europe Palmar Hyperhidrosis Treatment Market

22. Russia Palmar Hyperhidrosis Treatment Market

23. North America Palmar Hyperhidrosis Treatment Market

24. USA Palmar Hyperhidrosis Treatment Market

25. Canada Palmar Hyperhidrosis Treatment Market

26. South America Palmar Hyperhidrosis Treatment Market

27. Brazil Palmar Hyperhidrosis Treatment Market

28. Middle East Palmar Hyperhidrosis Treatment Market

29. Africa Palmar Hyperhidrosis Treatment Market

30. Palmar Hyperhidrosis Treatment Market Competitive Landscape And Company Profiles

31. Palmar Hyperhidrosis Treatment Market Other Major And Innovative Companies

32. Global Palmar Hyperhidrosis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Palmar Hyperhidrosis Treatment Market

34. Recent Developments In The Palmar Hyperhidrosis Treatment Market

35. Palmar Hyperhidrosis Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기